What is it about?
The purpose of this study was to investigate the ability of Alzheimer’s disease (AD) patients to express intentions and desires, and their decision-making capacity. This study examines the findings from a 6-month follow-up of our previous results in which 30 patients participated.
Featured Image
Why is it important?
The identification of impairment/deficits in writing and cognition during different phases of AD may facilitate the understanding of disease progression and identify the occasions during which the patient may be considered sufficiently lucid to make decisions
Read the Original
This page is a summary of: Legal medical consideration of Alzheimer’s disease patients’ dysgraphia and cognitive dysfunction a 6 month follow up, Clinical Interventions in Aging, March 2016, Dove Medical Press,
DOI: 10.2147/cia.s94750.
You can read the full text:
Contributors
The following have contributed to this page
